Q4 2025 Earnings Call February 26, 2026 4:30 PM ESTCompany ParticipantsMike Brophy - Chief Financial OfficerSteve Chapman - CEO ...
Thank you. Earlier today, Seer released financial results for the quarter and year ended December 31, 2025. If you've not received this news release or if you'd like to be added to the company's ...
Game Rant on MSN
Dragon Ball: All of Goku’s Zenkai Boosts, In Chronological Order
While a retcon introduced by DBZ, there are multiple moments in the original Dragon Ball where Goku gets stronger thanks to ...
AbCellera Biologics Inc. (NASDAQ: ABCL) Q4 2025 Earnings Call Transcript February 24, 2026 AbCellera Biologics Inc. beats ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and ...
Tech Xplore on MSN
Ultrafast 3D printing method creates complex objects in under a second
High-speed 3D printing has just gotten a lot faster. Researchers from Tsinghua University in China have developed a new high-speed printing technology capable of creating complex millimeter-scale ...
MHT CET 2026 registration date extended again! Apply by Feb 24 (regular) or Feb 27 (late fee) at cetcell.mahacet.org. Check exam dates, how to apply, and APAAR ID guide.
Scientists confirm meteorites contain all five DNA bases, indicating life's building blocks may have formed in space. Discover what this means for the origins of life.
A biomimetic synapse built from water droplets and biological ion channels achieves synaptic plasticity and performs machine learning tasks.
Ten percent complete response and rapid, durable antitumor activity reported with RYBREVANT FASPRO; results surpass current standards of care RARITAN, N.J., Feb. 19 ...
Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results